Benefits in projected pacemaker longevity and in pacing related costs conferred by automatic threshold tracking

PACE - Pacing and Clinical Electrophysiology

Volumn 23, Issue 11 II, 2000, Pages 1783-1787

  Boriani, Giuseppe ^a   Biffi, Mauro ^a   Branzi, Angelo ^a   Mininno, Antonio ^b   Sigliano, Riccardo ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b St Jude Medical Italia   (Italy)

Author keywords

Cardiac pacing; Cost effectiveness; Pacemaker longevity; Stimulation threshold

Indexed keywords

ADULT; AGED; ALGORITHM; ARTIFICIAL HEART PACEMAKER; CLINICAL ARTICLE; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; FEMALE; HEART ATRIUM FIBRILLATION; HEART PACING; HUMAN; MALE; PATIENT SELECTION;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ATRIAL FIBRILLATION; COST-BENEFIT ANALYSIS; ELECTRIC POWER SUPPLIES; ELECTRIC STIMULATION; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; SENSORY THRESHOLDS; TIME FACTORS;

EID: 0033665388     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2000.tb07018.x     Document Type: Article

References (11)

1. Basic concepts
2. Improvements in pacemaker energy consumption and functional capability: Four decades of progress
3. Italian experience with Autocapture in conjunction with a Membrane lead
4. Automatic adjustment of pacemaker stimulation output correlated with continuously monitored capture thresholds: A multicenter study
5. Myocardial stimulation threshold in patients with cardiac pacemakers: Effect of physiologic variables, pharmacologic agents and lead electrodes
6. The effect of age on heart rate in subjects free of heart disease
7. Mean 24 hour heart rate, minimal heart rate and pauses in healthy subjects 40-79 years of age
8. Cost benefit analysis of single and dual chamber pacing for sick sinus syndrome and atrioventricular block
9. Energy parameters in cardiac pacing should be abandoned
10. The cost effectiveness of dual chamber pacing
11. Alternative projections of mortality by cause 1990-2020: Global Burden of Disease Study